Vimarsana
Biggest News Aggregation in the World

Page 16 - Clinical Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Program Today - Breaking & Trending Today

Lobe Sciences Provides Update on L-130 Clinical Program - Vimarsana News

Lobe Sciences Provides Update on L-130 Clinical Program

Lobe Sciences Ltd. ("Lobe" or the "Company"), a biopharmaceutical company focused on developing transformative medicines to treat rare diseases today provided an update from the Company's lead clinical program, L-130, a proprietary stabilized...

Medtronic Announces FDA Approval of Minimally Invasive Device to Treat Hypertension - Vimarsana News

Medtronic Announces FDA Approval of Minimally Invasive Device to Treat Hypertension

Approval is the culmination of 10 years of clinical research and development of the Medtronic renal denervation technology

FDA OKs Symplicity Renal Denervation System for Hypertension - Vimarsana News

FDA OKs Symplicity Renal Denervation System for Hypertension

After a mixed FDA panel review in August, the agency has approved Medtronic's Symplicity Spyral renal denervation system for treatment of hypertension.

Medtronic announces FDA approval of minimally invasive device to treat hypertension - Vimarsana News

Medtronic announces FDA approval of minimally invasive device to treat hypertension

The Symplicity™ blood pressure procedure offers patients a new adjunct approach to lowering blood pressure Approval is the culmination of ten years of clinical research and development of the...

Apex Labs Applauds Senate Subcommittee's Endorsement for Expanded Access to Psychedelic-Assisted Therapy for Veterans - Vimarsana News

Apex Labs Applauds Senate Subcommittee's Endorsement for Expanded Access to Psychedelic-Assisted Therapy for Veterans

/PRNewswire/ - Apex Labs Ltd. (APEX or the Company), a pharmaceutical company transforming the standard of mental health care with psilocybin treatments...